Symptomatic venous thromboembolism after total knee replacement

被引:54
|
作者
Warwick, DJ [1 ]
Whitehouse, S [1 ]
机构
[1] BRISTOL KNEE GRP, BRISTOL, AVON, ENGLAND
来源
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 1997年 / 79B卷 / 05期
关键词
D O I
10.1302/0301-620X.79B5.7761
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Chemical prophylaxis is known to reduce the venographic prevalence of deep-vein thrombosis (DVT) after total knee replacement (TKR), but it is uncertain whether this affects the incidence of symptoms. Further analysis depends ion the basic epidemiology of thromboembolic symptoms, We therefore studied the pattern of such symptoms in a consecutive series of 1000 patients with primary TMR, with particular reference to risk factors and prophylaxis. We reviewed all the clinical records and contacted all the patients individually, noting risk factors, prophylaxis, symptomatic pulmonary embolus (PE) or DVT and its timing, death and its causes, and all complications, All the patients wore antiembolism stockings, 83% had regional anaesthesia and 33.9% had chemical prophylaxis. One patient died from PE on the day of surgery, having had no prophylaxis giving a rate of 0.1% (95% CI 0.003% to 0.56%). Symptomatic, radiologically confirmed thromboembolism (VTE) tvas common with a rate of 10.6% (95% CI 8.7% to 12.5%). There was a similar incidence of VTE in those with and without chemical prophylaxis (10.1% v 10.5%, RR 0.96, NS). VTE was more common in patients with risk factors (15.1% v 9.5%, RR 1.59, p = 0.02) and tended to occur earlier in this group (median day of onset 5 v 7, p = 0.01). Chemical prophylaxis did not reduce the frequency of symptomatic thromboembolism in either those with risk factors (RR 0.81, p = 0.5) or those without them (RR 0.94, p = 0.8). Haematoma or wound dehiscence was more common in those having chemical prophylaxis (11.9% v 6.9%; RR 1.73 95% CI 1.16 to 2.60). Readmission for symptomatic, radio-logically confirmed thromboembolism involved 1.1% of patients (95% CI 0.55% to 2.1%). Four patients were readmitted with proven non-fatal PE and six with proven DVT (the latest on day 40). Our results show that the main risk factor for thromboembolism was TKR itself; chemical prophylaxis did not reduce the incidence of symptomatic-thromboembolism but gave an increased perception of side-effects. Near prophylaxis methods or combinations of methods are needed, with their efficacy compared by randomised controlled studies of both the clinical and the radiological effect.
引用
收藏
页码:780 / 786
页数:7
相关论文
共 50 条
  • [21] Incidence of Symptomatic Venous Thromboembolism After Elective Knee Arthroscopy
    Maletis, Gregory B.
    Inacio, Maria C. S.
    Reynolds, Sarah
    Funahashi, Tadashi T.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (08): : 714 - 720
  • [22] Venous Thromboembolism Prophylaxis after Total Knee Arthroplasty
    Box, Hayden N.
    Shahrestani, Sean
    Huo, Michael H.
    JOURNAL OF KNEE SURGERY, 2018, 31 (07) : 605 - 609
  • [23] INCIDENCE AND PREVENTION OF THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT
    MCKENNA, R
    BACHMANN, F
    GALANTE, J
    KAUSHAL, SP
    MEREDITH, P
    CLINICAL RESEARCH, 1976, 24 (04): : A572 - A572
  • [24] Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China
    Xiaoyu Yan
    Xiaohua Gu
    Lei Zhou
    Houweng Lin
    Bin Wu
    Clinical Drug Investigation, 2016, 36 : 1001 - 1010
  • [25] Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China
    Yan, Xiaoyu
    Gu, Xiaohua
    Zhou, Lei
    Lin, Houweng
    Wu, Bin
    CLINICAL DRUG INVESTIGATION, 2016, 36 (12) : 1001 - 1010
  • [26] ECONOMIC EVALUATIONS OF NEW ORAL ANTICOAGULANTS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT
    Brockbank, J.
    Wolowacz, S.
    VALUE IN HEALTH, 2015, 18 (07) : A392 - A392
  • [27] The prevalence of venous thromboembolism after hip and knee replacement surgery
    O'Reilly, RF
    Burgess, IA
    Zicat, B
    MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (04) : 154 - 159
  • [28] Venous thromboembolism after elective hip and knee replacement surgery
    Haas, Sylvia
    Lassen, Michael Rud
    EJHP PRACTICE, 2010, 16 (01): : 17 - 19
  • [29] ECONOMIC EVALUATION OF APIXABAN FOR VENOUS THROMBOEMBOLISM IN TOTAL KNEE AND TOTAL HIP REPLACEMENT IN GUATEMALA
    Lutz, M. A.
    Gordillo, D., I
    Bogantes, J. P.
    Cuesta, G.
    VALUE IN HEALTH, 2013, 16 (03) : A288 - A288
  • [30] Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review
    Asma Rashki Kemmak
    Ali Abutorabi
    Vahid Alipour
    Clinical Drug Investigation, 2020, 40 : 715 - 725